FDA to allow 23andMe to report more BRCA variants; Janssen secures deal with AI-drug discovery outfit
23andMe received FDA clearance to report an additional 41 variants in the BRCA1 and BRCA2 genes, which are associated with a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
